Structural and biochemical characterization of the vaccinia virus: Envelope protein D8 and its recognition by the antibody LA5

Journal of Virology

Volumn 86, Issue 15, 2012, Pages 8050-8058

  Matho, Michael H ^a   Maybeno, Matt ^a   Benhni, Mohammed Rafii El Idrissi ^a,c   Becker, Danielle ^a   Meng, Xiangzhi ^a   Xiang, Yan ^b   Crotty, Shane ^a   Peters, Bjoern ^a   Zajonc, Dirk M ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c UNIVERSITY OF SEVILLE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

D8 PROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY LA5; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; BINDING AFFINITY; BINDING SITE; CRYSTAL STRUCTURE; MOLECULAR DOCKING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FOLDING; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; STRUCTURE ANALYSIS;

ANIMALS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIBODIES, VIRAL; BINDING SITES; CERCOPITHECUS AETHIOPS; CRYSTALLOGRAPHY, X-RAY; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MICE; PROTEIN STRUCTURE, QUATERNARY; VACCINIA VIRUS; VERO CELLS; VIRAL ENVELOPE PROTEINS;

POXVIRIDAE; VACCINIA VIRUS; VARIOLA VIRUS;

EID: 84864387275     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00836-12     Document Type: Article

References (58)

1. Amanna IJ, Slifka MK, Crotty S. 2006. Immunity and immunological memory following smallpox vaccination. Immunol. Rev. 211:320-337.
2. Atlas RM. 2002. Bioterriorism: from threat to reality. Annu. Rev. Microbiol. 56:167-185.
3. Battye TG, Kontogiannis L, Johnson O, Powell HR, Leslie AG. 2011. iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM. Acta Crystallogr. D Biol. Crystallogr. 67:271-281.
4. Benhnia MR, et al. 2009. Heavily isotype-dependent protective activities of human antibodies against vaccinia virus extracellular virion antigen B5. J. Virol. 83:12355-12367.
5. Benhnia MR, et al. 2009. Vaccinia virus extracellular enveloped virion neutralization in vitro and protection in vivo depend on complement. J. Virol. 83:1201-1215.
6. Benhnia MR, et al. 2008. Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine. J. Virol. 82:3751-3768.
7. Berhanu A, et al. 2008. Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge. J. Virol. 82:3517-3529.
8. Bordoli L, et al. 2009. Protein structure homology modeling using SWISS-MODEL workspace. Nat. Protoc. 4:1-13.
9. Boriack-Sjodin PA, et al. 1998. Structural analysis of inhibitor binding to human carbonic anhydrase II. Protein Sci. 7:2483-2489.
10. Braden BC, Fields BA, Poljak RJ. 1995. Conservation of water molecules in an antibody-antigen interaction. J. Mol. Recognit. 8:317-325.
11. Brochet X, Lefranc MP, Giudicelli V. 2008. IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J. and V-D-J. sequence analysis. Nucleic Acids Res. 36:W503-508.
12. Chung CS, et al. 2006. Vaccinia virus proteome: identification of proteins in vaccinia virus intracellular mature virion particles. J. Virol. 80:2127-2140.
13. Chung CS, Hsiao JC, Chang YS, Chang W. 1998. A27L protein mediates vaccinia virus interaction with cell surface heparan sulfate. J. Virol. 72: 1577-1585.
14. Collaborative Computational Project, Number 4. 1994. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 50:760-763.
15. Crotty S, et al. 2003. Long-term B cell memory in humans after smallpox vaccination. J. Immunol. 171:4969-4973.
16. Davies DH, et al. 2005. Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice. J. Virol. 79:11724-11733.
17. Davies DH, et al. 2007. Proteome-wide analysis of the serological response to vaccinia and smallpox. Proteomics 7:1678-1686.
18. Di Giulio DB, Eckburg PB. 2004. Human monkeypox: an emerging zoonosis. Lancet Infect. Dis. 4:15-25.
19. Dolinsky TJ, Nielsen JE, McCammon JA, Baker NA. 2004. PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations. Nucleic Acids Res. 32:W665-W667.
20. Edghill-Smith Y, et al. 2005. Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus. Nat. Med. 11:740-747.
21. Emsley P, Lohkamp B, Scott WG, Cowtan K. 2010. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66:486-501.
22. Gouy M, S Guindon and O Gascuel. 2010. SeaView version 4: a multiplatform graphical user interface for sequence alignment and phylogenetic tree building. Mol. Biol. Evol. 27:221-224.
23. Hammarlund E, et al. 2005. Multiple diagnostic techniques identify previously vaccinated individuals with protective immunity against monkeypox. Nat. Med. 11:1005-1011.
24. Host G, Martensson LG, Jonsson BH. 2006. Redesign of human carbonicanhydrase II for increased esterase activity and specificity towards esters with long acyl chains. Biochim. Biophys. Acta 1764:1601-1606.
25. Hsiao JC, Chung CS, Chang W. 1998. Cell surface proteoglycans are necessary for A27L protein-mediated cell fusion: identification of the Nterminal region of A27L protein as the glycosaminoglycan-binding domain. J. Virol. 72:8374-8379.
26. Izmailyan RA, Huang CY, Mohammad S, Isaacs SN, Chang W. 2006. The envelope G3L protein is essential for entry of vaccinia virus into host cells. J. Virol. 80:8402-8410.
27. Janeczko RA, Rodriguez JF, Esteban M. 1987. Studies on the mechanism of entry of vaccinia virus in animal cells. Arch. Virol. 92:135-150.
28. Karem KL, et al. 2007. Monkeypox-induced immunity and failure of childhood smallpox vaccination to provide complete protection. Clin. Vaccine Immunol. 14:1318-1327.
29. Lawrence MC, Colman PM. 1993. Shape complementarity at protein/ protein interfaces. J. Mol. Biol. 234:946-950.
30. Li Z, Kienetz M, Cherney MM, James MN, Bromme D. 2008. The crystal and molecular structures of a cathepsin K:chondroitin sulfate complex. J. Mol. Biol. 383:78-91.
31. Lin CL, Chung CS, Heine HG, Chang W. 2000. Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivo. J. Virol. 74:3353-3365.
32. Lo Conte L, Chothia C, Janin J. 1999. The atomic structure of proteinprotein recognition sites. J. Mol. Biol. 285:2177-2198.
33. Lovell SC, et al. 2003. Structure validation by Calpha geometry: phi,psi and Cbeta deviation. Proteins 50:437-450.
34. McCausland MM, et al. 2010. Combination therapy of vaccinia virus infection with human anti-H3 and anti-B5 monoclonal antibodies in a small animal model. Antivir. Ther. 15:661-675.
35. Meng X, et al. 2011. Generation and characterization of a large panel of murine monoclonal antibodies against vaccinia virus. Virology 409:271-279.
36. Moss B. 2007. Poxviridae: the viruses and their replication, p 2905-2946. In Knipe DM, Howley PM (ed), Fields virology, 5th ed, vol 2. Lippincott Williams & Wilkins, Hagerstown, MD.
37. Moss B. 2011. Smallpox vaccines: targets of protective immunity. Immunological reviews. 239:8-26.
38. Mourey RJ, Dixon JE. 1994. Protein tyrosine phosphatases: characterization of extracellular and intracellular domains. Curr. Opin. Genet. Dev. 4:31-39.
39. Murshudov GN, Vagin AA, Dodson EJ. 1997. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D Biol. Crystallogr. 53:240-255.
40. Niles EG, Seto J. 1988. Vaccinia virus gene D8 encodes a virion transmembrane protein. J. Virol. 62:3772-3778.
41. Ohradanova A, et al. 2007. Reconstitution of carbonic anhydrase activity of the cell-surface-binding protein of vaccinia virus. Biochem. J. 407:61-67.
42. Ojeda S, Senkevich TG, Moss B. 2006. Entry of vaccinia virus and cell-cell fusion require a highly conserved cysteine-rich membrane protein encoded by the A16L gene. J. Virol. 80:51-61.
43. Painter J, Merritt EA. 2006. Optimal description of a protein structure in terms of multiple groups undergoing TLS motion. Acta Crystallogr. D Biol. Crystallogr. 62:439-450.
44. Reed KD, et al. 2004. The detection of monkeypox in humans in the Western Hemisphere. N. Engl. J. Med. 350:342-350.
45. Regnery RL. 2007. Poxviruses and the passive quest for novel hosts. Curr. Top. Microbiol. Immunol. 315:345-361.
46. Rodriguez JR, Rodriguez D, Esteban M. 1992. Insertional inactivation of the vaccinia virus 32-kilodalton gene is associated with attenuation in mice and reduction of viral gene expression in polarized epithelial cells. J. Virol. 66:183-189.
47. Satheshkumar PS, Moss B. 2009. Characterization of a newly identified 35-amino-acid component of the vaccinia virus entry/fusion complex conserved in all chordopoxviruses. J. Virol. 83:12822-12832.
48. Senkevich TG, Moss B. 2005. Vaccinia virus H2 protein is an essential component of a complex involved in virus entry and cell-cell fusion. J. Virol. 79:4744-4754.
49. Senkevich TG, Ward BM, Moss B. 2004. Vaccinia virus entry into cells is dependent on a virion surface protein encoded by the A28L gene. J. Virol. 78:2357-2366.
50. Su HP, et al. 2005. The 1.51-angstrom structure of the poxvirus L1 protein, a target of potent neutralizing antibodies. Proc. Natl. Acad. Sci. U. S. A. 102:4240-4245.
51. Su HP, Golden JW, Gittis AG, Hooper JW, Garboczi DN. 2007. Structural basis for the binding of the neutralizing antibody, 7D11, to the poxvirus L1 protein. Virology 368:331-341.
52. Su HP, Singh K, Gittis AG, Garboczi DN. 2010. The structure of the poxvirus A33 protein reveals a dimer of unique C-type lectin-like domains. J. Virol. 84:2502-2510.
53. Tiller T, Busse CE, Wardemann H. 2009. Cloning and expression of murine Ig genes from single B cells. J. Immunol. Methods 350:183-193.
54. Townsley AC, Senkevich TG, Moss B. 2005. The product of the vaccinia virus L5R gene is a fourth membrane protein encoded by all poxviruses that is required for cell entry and cell-cell fusion. J. Virol. 79:10988-10998.
55. Townsley AC, Senkevich TG, Moss B. 2005. Vaccinia virus A21 virion membrane protein is required for cell entry and fusion. J. Virol. 79:9458-9469.
56. Trott O, Olson AJ. 2010. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31:455-461.
57. Tsung K, Yim JH, Marti W, Buller RM, Norton JA. 1996. Gene expression and cytopathic effect of vaccinia virus inactivated by psoralen and long-wave UV light. J. Virol. 70:165-171.
58. Vagin A, Teplyakov A. 2010. Molecular replacement with MOLREP. Acta Crystallogr. D Biol. Crystallogr. 66:22-25.